reprai today announced the launch of effichannel, a new strategic approach designed to solve one of the pharmaceutical industry's biggest challenges: ineffective, high-volume communication that fails to meet the real needs of healthcare professionals (HCPs).

With only 28% of HCPs saying current engagement strategies meet their needs, the industry can no longer rely on crowded omnichannel tactics. effichannel addresses this by prioritizing relevance, timing, and measurable value over frequency and channel expansion.

“Industry doesn’t need more messages, they need better ones. effichannel is our answer to years of overload in pharma engagement. It brings efficiency, clarity, and real impact back into communication. With reprai, pharma marketing teams can finally focus on what works, not what’s louder.” Didem Aral, CEO, reprai

A Shift From ‘More’ to ‘Efficient’

effichannel moves pharma from quantity-driven communication to impact-driven engagement, focusing on timely, personalized, and purposeful interactions. Instead of relying on redundant email blasts, generic content, or fixed campaign calendars, effichannel aligns communication with real HCP behavior and intent signals, delivering the right message at the right moment. It prioritizes relevance, automation, and scalability over the outdated “more channels, more messages” mindset.

To support this shift, reprai’s AI-powered platform provides always-on digital rep capabilities, automated promotional workflows, and real-time content personalization — giving companies the infrastructure needed to operationalize the effichannel model at scale.

The transition to effichannel is structured through four key steps: assessing current tools, redesigning engagement strategy, automating where it matters, and continuous optimization, empowering brands to scale effectively and with clarity.